Enbrel 50 mg solution for injection in pre-filled syringe, Enbrel 50 mg solution for injection in pre-filled syringe
MB04-C-01-23
Phase 3 small_molecule active
Quick answer
Enbrel 50 mg solution for injection in pre-filled syringe, Enbrel 50 mg solution for injection in pre-filled syringe for Rheumatoid Arthritis is a Phase 3 program (small_molecule) at Mabxience Research SL with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mabxience Research SL
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active